CI Investments Inc
VKTX icon

CI Investments Inc’s Viking Therapeutics VKTX Stock Holding History

CI Investments Inc’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,699
Closed -$41K – 1349
2025
Q1 		$41K Sell
1,699
-1,021
-38% -$32.3K ﹤0.01% 1057
2024
Q4 		$109K Buy
2,720
+259
+11% +$14.8K ﹤0.01% 919
2024
Q3 		$156K Buy
2,461
+88
+4% +$5.16K ﹤0.01% 729
2024
Q2 		$126K Sell
2,373
-168,756
-99% -$11.1M ﹤0.01% 753
2024
Q1 		$14M Buy
+171,129
New +$7.61M 0.06% 203

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CI Investments Inc's VKTX Position: Q2 2025 in Review

CI Investments Inc sold out of Viking Therapeutics (VKTX) in Q2 2025, closing a stake of 1,699 shares — an estimated $41K sold.

CI Investments Inc first reported a position in VKTX in Q1 2024 and held it in 5 quarters. The position peaked at $14M in Q1 2024. 392 funds tracked by Wall St. Rank hold VKTX as of Q2 2025.

  • CI Investments Inc reported no remaining Viking Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 1,699 Viking Therapeutics shares in Q2 2025, an estimated $41K.
  • CI Investments Inc first reported a position in Viking Therapeutics in Q1 2024 and held it in 5 quarters.
  • CI Investments Inc's Viking Therapeutics position peaked at $14M in Q1 2024.
  • 392 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.